Angiotensin Ii type 1 receptor antagonists in cardiac insufficiency
González-Juanatey, J.R.; Vallés Belsué, F.
Medicina Clinica 114(Suppl 1): 43-45
2000
ISSN/ISBN: 0025-7753 PMID: 10812575 Document Number: 513738
Document emailed within 1 workday
Related Documents
Javier Trujillo-Santos, A.; Poveda-Gómez, F.; García-Alegría, J. 2002: Angiotensin Ii receptor antagonists in cardiac failure treatment Medicina Clinica 118(9): 347-352Schnack, C.; Schernthaner, G. 2001: Angiotensin Ii type-1 receptor antagonists and diabetes mellitus Wiener Medizinische Wochenschrift 151(7-8): 165-168
Paul, B.; Goyal, R.K. 2000: Angiotensin Ii type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why? Indian Heart Journal 52(1): 19-22
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57
Tachikawa, H.; Kodama, M.; Hui, L.; Yoshida, T.; Hayashi, M.; Abe, S.; Kashimura, T.; Kato, K.; Hanawa, H.; Watanabe, K.; Nakazawa, M.; Aizawa, Y. 2003: Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis Journal of Cardiovascular Pharmacology 41(Suppl): S105-S110
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Bornkessel, B. 1995: Angiotensin Ii receptor antagonists Medizinische Monatsschrift für Pharmazeuten 18(6): 148-151
Chung, O.; Unger, T. 1996: Angiotensin Ii receptor antagonists Der Internist 37(5): 534-538; Discussion 538
Timofeeva, N.I.; Snetkova, A.A.; Zadionchenko, V.S. 2013: Angiotensin Ii receptor antagonists in cardiology: course to organoprotection Kardiologiia 53(3): 88-93
Scholze, J. 1996: Angiotensin Ii receptor antagonists. Clinical relevance Der Internist 37(6): 636-642
Mareev, V.I.; Lopatin, I.M.; Dzhakhangirov, T.S.; Gkhani, P.; Ageev, F.T.; Belenkov, I.N. 1993: Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency Kardiologiia 33(12): 23-31; 3-4
Dimitrov, Y.; Muller, S.; Hannedouche, T. 1997: Renal effects of AT1 angiotensin receptor antagonists (AT1ra) Presse Medicale 26(40): 1981-1986
Higashiura, K.; Shimamoto, K. 1999: The effects of angiotensin Ii receptor antagonists on insulin resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 57(5): 1182-1186
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703
Laudanno, O.M.; Cesolari, J.é A.M. 2006: Angiotensin Ii AT1 receptor antagonists as antiinflammatory and gastric protection drugs Acta Gastroenterologica Latinoamericana 36(2): 76-80
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Masłyk, T.; Romanowska-Sarlej, J.; Kifer-Wysocka, E.; Matysiak, W.ło.; Czerny, K. 2004: Morphological changes in adrenal cortex--the final effect of angiotensin Ii receptor antagonists Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 59(2): 129-133